A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/07/2006	US7132262 administering codon optimized polynucleotides that code human papillomavirus polypeptides comprising early proteins or fragments to cells of mammals; gene therapy; DNA vaccines
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132246 Use of soluble cytokeratin-1-fragments in diagnostics and therapy
11/07/2006	US7132234 or drug targets; contacting a poxviral p28 polypeptide with a candidate agent, and determining an effect on ubiquitin ligase activity of the p28; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) drug discovery
11/07/2006	US7132232 Diagnosing mammary gland cancer; obtain mammary gland fluid, detect preferential virus in fluid, evaluate for cancer
11/07/2006	US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	US7132109 Administering to the subject a vaccine comprising component against which an immune response is desired to be induced; administering to the subject a heat shock protein preparation which does not display immunogenicity of the component
11/07/2006	US7132108 Immunizing poultry from infection from Salmonella enteritidis by administering a total dose of killed S. enteritidis of 0.15 to 15 mg, administered as a single dose, of a suspension of microspheres comprising killed S. enteritidis encapsulated in porous poly(lactide-coglycolide) copolymer shell
11/07/2006	US7132107 For prophylaxis and therapy of prevention and pneumococcal infection
11/07/2006	US7132106 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
11/07/2006	US7132105 Icosahedral superstructure of VP2 of infectious bursitis virus (IBDV) and the application thereof
11/07/2006	US7132104 Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
11/07/2006	US7132102 Bacteriocin isolated from Lactobacillus salivarius deposited with United States Department of Agricultural, Agricultural Research Service Patent Culture Collection as Accession Number NRRL-B30514; used for reducing the levels of colonization by a target bacteria in animals, especially poultry
11/07/2006	US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006	US7132100 Palivizumab formulation comprising in aqueous carrier at least 40 mg/ml of palivizumab, or an antigen-binding fragment thereof and histidine, wherein formulation is free of surfactants and inorganic salts; for preventing or treating symptoms associated with a respiratory syncytial virus infection
11/07/2006	US7132099 Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
11/07/2006	CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006	CA2226436C Generation of immune responses to prostate-specific antigen (psa)
11/07/2006	CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/07/2006	CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/02/2006	WO2006116763A2 Lawsonia intracellularis immunological proteins
11/02/2006	WO2006116702A2 Inducible nitric oxide synthase binds, s-nitrosylates, and activates cyclooxygenase-2
11/02/2006	WO2006116660A2 Methods of inhibiting a gpr23
11/02/2006	WO2006116546A1 Surface-modified microparticles and methods of forming and using the same
11/02/2006	WO2006116475A2 Immunostimulatory compositions
11/02/2006	WO2006116463A2 Convertible top mechanism with inwardly articulating rearmost lateral rails
11/02/2006	WO2006116423A2 Compositions and methods for cancer immunotherapy
11/02/2006	WO2006116381A2 Plasma or serum fraction for treatment or prevention of abnormal cell proliferation
11/02/2006	WO2006116380A2 Plasma or serum fraction for the treatment or prevention of bacterial infections
11/02/2006	WO2006116366A2 Methods for treating disease by regulating cll cell survival
11/02/2006	WO2006116325A2 Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor
11/02/2006	WO2006116319A2 Reagents that bind ccx-ckr2
11/02/2006	WO2006116269A2 Antibodies to myostatin
11/02/2006	WO2006116246A2 Method of treating cd30 positive lymphomas
11/02/2006	WO2006116192A2 Irta-1 antibodies and their uses
11/02/2006	WO2006116185A2 Methods for the treatment of multiple myeloma
11/02/2006	WO2006116182A1 Recombinant flavivirus vaccines
11/02/2006	WO2006116082A1 Materials and methods for respiratory disease control in canines
11/02/2006	WO2006116053A1 Immunomodulator compounds as vaccine enhancers
11/02/2006	WO2006116001A2 Antibodies for the treatment of cancers
11/02/2006	WO2006115800A2 Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha
11/02/2006	WO2006115548A2 Subunit vaccine against west nile viral infection
11/02/2006	WO2006115413A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	WO2006115295A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
11/02/2006	WO2006114805A2 Use of hmgb2 and hmgb3 proteins for medical applications
11/02/2006	WO2006114704A2 P-cadherin antibodies
11/02/2006	WO2006114307A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	WO2006114284A2 AGONISTIC ANTIBODIES THAT BIND TO THE LT-β-RECEPTOR AND THEREBY MODULATE ADIPOSITY-ASSOCIATED PHENOTYPES AS WELL AS THEIR USE IN THERAPY
11/02/2006	WO2006114115A1 Combination of antibodies and glucocorticoids for treating cancer
11/02/2006	WO2006092457A3 Method and vaccine strategies for potentiating the immune response to prions following vaccination, diagnostic kits and pharmaceutical compositions for the prophylaxis and treatment of spongiform encephalopathies
11/02/2006	WO2006089133A8 Anti-cd19 antibodies and uses in oncology
11/02/2006	WO2006088890A3 Treating stroke
11/02/2006	WO2006088740A3 Methods and compositions for impairing multiplication of hiv-1
11/02/2006	WO2006087756A3 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
11/02/2006	WO2006081822A3 Minor allergen control to increase safety of immunotherapy
11/02/2006	WO2006081007A3 Use of flagellin in tumor immunotherapy
11/02/2006	WO2006077592A3 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
11/02/2006	WO2006055809A3 Antibodies against vascular endothelial growth factor receptor-1
11/02/2006	WO2006050343A3 Monoclonal antibodies to the propeptide of candida albicans and methods of use
11/02/2006	WO2006042027A8 Immunogenic and therapeutic compositions for streptococcus pyogenes
11/02/2006	WO2005110493A8 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
11/02/2006	WO2005095442A8 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
11/02/2006	WO2005004793A9 Compositions and methods for treating coagulation related disorders
11/02/2006	WO2004032711A3 Diagnosis and monitoring of inflammation, ischemia and appendicitis
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247425 Glycosylated immunoglobulin and immunoadhesin comprising the same
11/02/2006	US20060247316 Food supplement
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246525 Method of screening remedy for heart disease and medicinal composition for treating heart disease
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246448 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/02/2006	US20060246126 Therapeutic liposome composition and method of preparation
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246095 Multiepitope polypeptides for cancer immunotherapy
11/02/2006	US20060246094 Inactivated vibrio cholerae vaccine in tablet form
11/02/2006	US20060246093 Implant analog
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246091 Avidin-pseudotyped viral vectors and their use
11/02/2006	US20060246090 Vaccine against hcv
11/02/2006	US20060246089 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
11/02/2006	US20060246088 Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246086 Virulence genes and proteins from Brucella melitensis, and their use
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246084 Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins
11/02/2006	US20060246083 Protective antigen of group a streptococci
11/02/2006	US20060246082 Therapeutic peptides and method
11/02/2006	US20060246081 Methods and compositions for polytopic vaccination
11/02/2006	US20060246080 Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
11/02/2006	US20060246079 Neutralizing human antibodies to anthrax toxin
11/02/2006	US20060246078 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen

1 ... 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 ... 1823